col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

87 Results       Page 1

Elsevier: Metabolism
  original article Date Title Authors   All Authors
1 [GO] 2024―Jun―15 Diabetics and Insulin Resistant Patients, Especially Post COVID-19, Have an Increased Biologic Age From Analysis of Brain FDG PET H.T. Pretorius, G.M. Hubbell, B. Budke, N.M. Bodnar, B. Murray, B.M. Brosal, D. Menke
2 [GO] 2024―Apr―18 Virus-induced diabetes mellitus, revisiting infection etiology in light of SARS-CoV-2 Sundararaj Stanleyraj Jeremiah, Abu Saleh Md Moin, Alexandra E. Butler
3 [GO] 2024―Feb―13 Mortality risk in patients with obesity and COVID-19 infection: a systematic review and meta-analysis Haber Rachelle, Ghezzawi Malak, Puzantian Houry, Haber Marc, Saad Sacha, Ghandour Yara, et al. (+10)
4 [GO] 2023―Nov―01 Epicardial adipose tissue measured from analysis of adipose tissue area using chest CT imaging is the best potential predictor of COVID-19 severity Takahiro Fukushima, Tomoki Maetani, Shotaro Chubachi, Naoya Tanabe, Takanori Asakura, Ho Namkoong, et al. (+27)
5 [GO] 2023―May―09 Analysis of Cardiovascular Complications during Delivery Admissions Associated with COVID-19 Salman Zahid, Ankit Agrawal, Devesh Rai, Muhammad Zia Khan, Erin D. Michos
6 [GO] 2023―May―09 Lifestyle and Affective Emotions in Patients with Type 2 Diabetes Mellitus, With or Without COVID-19 History Cesar Ochoa, Nallely Dolores Guerra Olivares, Roxana del Socorro González Dzib, Tania M. Peña Arriaga
7 [GO] 2023―May―09 Outcome of Cardiovascular Diseases in Covid-19 Patients in a Tertiary Care Hospital in South India Judah Rajendran, Shivani Ravichandran, Mathan Karthik m, Nayyar Iqbal
8 [GO] 2023―Jan―31 Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the ANRS0001S COV-POPART cohort Gaborit Bénédicte, Fernandes Sara, Loubet Paul, Ninove Laetitia, Dutour Anne, Cariou Bertrand, et al. (+12)
9 [GO] 2022―Oct―08 Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis Honghao Lai, Manli Yang, Mingyao Sun, Bei Pan, Quan Wang, Jing Wang, et al. (+5)
10 [GO] 2022―Jul―25 Cross-talk between SARS-CoV-2 infection and the insulin/IGF signaling pathway: implications for metabolic diseases in COVID-19 and for post-acute sequelae of SARS-CoV-2 infection Theodoros Kelesidis, Christos S. Mantzoros
11 [GO] 2022―Jun―08 SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1 Jihoon Shin, Shinichiro Toyoda, Shigeki Nishitani, Toshiharu Onodera, Shiro Fukuda, Shunbun Kita, et al. (+2)
12 [GO] 2022―May―26 COVID-19 and sulfonylureas: A reminder of the pleiotropic actions of an old class of drugs just before their swansong Theocharis Koufakis, Djordje S. Popovic, Symeon Metallidis, Kalliopi Kotsa
13 [GO] 2022―May―15 A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on Chrysoula Boutari, Christos S. Mantzoros
14 [GO] 2022―Apr―02 Machine learning and semi-targeted lipidomics identify distinct serum lipid signatures in hospitalized COVID-19-positive and COVID-19-negative patients Helena Castañé, Simona Iftimie, Gerard Baiges-Gaya, Elisabet Rodríguez-Tomàs, Andrea Jiménez-Franco, Ana Felisa López-Azcona, et al. (+4)
15 [GO] 2022―Apr―01 Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis Nam Nhat Nguyen, Dung Si Ho, Hung Song Nguyen, Dang Khanh Ngan Ho, Hung-Yuan Li, Chia-Yuan Lin, et al. (+2)
16 [GO] 2022―Mar―18 Reduced DMPC and PMPC in lung surfactant promote SARS-CoV-2 infection in obesity Kang Du, Ling Sun, Zichen Luo, Yang Cao, Qiushi Sun, Kangzhen Zhang, et al. (+5)
17 [GO] 2022―Mar―03 Cardio-metabolic factors associated to mortality in patients with COVID-19 Camey Eduardo, Arauz Guillermo, Cárcamo Alejandra, Celis Grecia
18 [GO] 2022―Mar―03 COVID-19 and metabolic syndrome H. Chaabouni, F. Smaoui, K. Mnif, K. Rekik, C. Marrakchi, M. Koubaa, M. Ben Jemaa
19 [GO] 2022―Mar―03 Influence of metabolic syndrome components in the course of covid-19 in patients with nonalcoholic fatty liver disease Guzal Naimovna Sobirova, Zarnigor Orifovna Bafoeva, Mirvasit Mirvasikovich Karimov
20 [GO] 2022―Mar―03 Challenges of diabetes management during COVID-19 infection H. Chaabouni, F. Smaoui, K. Mnif, K. Rekik, C. Marrakchi, M. Koubaa, M. Ben Jemaa
21 [GO] 2022―Mar―03 Impact of COVID-19 outbreak in health care of people with type 2 diabetes: evidence from a cross-sectional study in Albania Fatjona Kamberi, Jerina Jaho, Enkeleda Sinaj, Vjollca Ndreu, Ilirjana Zekja
22 [GO] 2022―Mar―03 Gestational Diabetes Mellitus: increased incidence during the COVID-19 pandemic Hala Boutrid, Nada Boutrid, S. Chaat, M. Keghouche, H. Rahmoune, F. Madaci
23 [GO] 2022―Mar―03 Challenges for Effective Glycemic control in T2DM during Covid-19 pandemic and Use of Glimepiride/Metformin FDC: Opinion from Indian Clinicians Alka Gandhi, C.R. Anand Moses, Nilesh Detroja, Ajay Ajmani, Mahesh Abhyankar
24 [GO] 2022―Mar―03 New onset Diabetes Mellitus in a COVID-19 patient: A Case report Karam R. Motawea, Kirellos Said Abbas, Yossef Hassan AbdelQadir, Fatma A. Monib
25 [GO] 2022―Mar―03 The impact of chronic kidney disease in diabetic COVID-19 patients Hana Chaabouni, Ichrak Bougharriou, Khouloud Mnif, Majdi Maazoun, Tarak Ben Jemaa, Khaoula Rekik, et al. (+5)
26 [GO] 2022―Mar―03 COVID-19 related morbidity and mortality among patients with diabetes H. Chaabouni, F. Smaoui, K. Mnif, K. Rekik, C. Marrakchi, M. Koubaa, M. Ben Jemaa
27 [GO] 2022―Mar―03 The influence of metformin on the rate of Covid-19 vaccination among diabetes type 2 patients in Poland Daniel Bałut, Marcin Kleibert, Patrycja Małgorzata Bąk, Jakub Zieliński, Beata Mrozikiewicz-Rakowska
28 [GO] 2022―Mar―03 Diet-induced obesity and NASH aggravate SARS-CoV-2 infection in golden Syrian hamsters François Briand, Valentin Sencio, Thierry Sulpice, François Trottein
29 [GO] 2022―Jan―29 Mendelian randomization study of obesity and type 2 diabetes in hospitalized COVID-19 patients Hui-Qi Qu, Jingchun Qu, Joseph Glessner, Hakon Hakonarson
30 [GO] 2022―Jan―10 Editorial: Obesity, metabolic phenotypes and COVID-19 Despina Sanoudou, Michael A. Hill, Matthew J. Belanger, Kevin Arao, Christos S. Mantzoros
31 [GO] 2021―Oct―27 Systematic review with meta-analysis of diagnostic test accuracy for COVID-19 by mass spectrometry Matt Spick, Holly M. Lewis, Michael J. Wilde, Christopher Hopley, Jim Huggett, Melanie J. Bailey
32 [GO] 2021―Sep―30 Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity Nam Hoon Kim, Kyeong Jin Kim, Jimi Choi, Sin Gon Kim
33 [GO] 2021―Aug―05 Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19 Stefania L. Calvisi, Giuseppe A. Ramirez, Marina Scavini, Valentina Da Prat, Giuseppe Di Lucca, Andrea Laurenzi, et al. (+13)
34 [GO] 2021―Jul―30 Diabetic ketoacidosis in pediatric patients with type1- and type2 diabetes during the COVID-19 pandemic Charlotte Loh, Paul Weihe, Nicole Kuplin, Kerstin Placzek, Susann Weihrauch-Blüher
35 [GO] 2021―Jun―29 Obesity and COVID-19 mortality Yadong Wang, Jie Xu, Ying Wang, Hongjie Hou, Huifen Feng, Haiyan Yang
36 [GO] 2021―Jun―11 Diabetes and COVID-19: The Past, The Present, and The Future Raymond Pranata, Joshua Henrina, Wilson Matthew Raffaello, Sherly Lawrensia, Ian Huang
37 [GO] 2021―Mar―26 COVID-19 Editorial: Mechanistic Links and Daunting Therapeutic Challenges for Metabolic Diseases One Year after The Beginning of The COVID-19 Pandemic Christopher M. Tessier, Alexander Kokkinos, Geltrude Mingrone, Chrysi Koliaki, Juleen R. Zierath, Christos S. Mantzoros
38 [GO] 2021―Mar―24 The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis Aya Bassatne, Maya Basbous, Marlene Chakhtoura, Ola El Zein, Maya Rahme, Ghada El-Hajj Fuleihan
39 [GO] 2021―Mar―02 The serum metabolome of COVID-19 patients is distinctive and predictive Ding Shi, Ren Yan, Longxian Lv, Huiyong Jiang, Yingfeng Lu, Jifang Sheng, et al. (+10)
40 [GO] 2021―Feb―23 Impact of body composition on COVID-19 susceptibility and severity: a two-sample multivariable Mendelian randomization study Dennis Freuer, Jakob Linseisen, Christa Meisinger
41 [GO] 2021―Feb―04 COVID-19 letter to the editor: Epicardial fat inflammation as possible enhancer in COVID-19? Yuhao Zhao, Mulei Chen, Xinchun Yang, Lei Zhao
42 [GO] 2021―Jan―29 Improving Glycemic Control in Patients With COVID-19 : A Quality Improvement Project N.A. Jadoon, S. Noor, M. Iqbal, N. Pervez
43 [GO] 2021―Jan―29 Remote Monitoring of Pregnancies Complicated by Gestational Diabetes Mellitus during the COVID-19 : Lockdown Using STORK Christos Chatzakis, Dimitrios Floros, Nikolaos Pitsianis, Alexandros Sotiriadis
44 [GO] 2021―Jan―29 Continuous Blood Glucose Monitoring to Determine Glycemic Variability in Patients Having COVID-19 Infection and Its Bearing on the Severity of the Disease Archit Jain, Jitendra D. Lakhani, Hetal Pandya
45 [GO] 2021―Jan―29 Systematic Review and Meta-Analysis of the Observational Trials Evaluating the Functional Impact of COVID-19 on Sexual Health Deepak Jumani, Abhishek Jumani, Shashank Joshi, Ghufran Lufti Ismaeel
46 [GO] 2021―Jan―29 Association Between BMI and Food Quality in Adults During COVID-19 Pandemic, Albania Brunilda Subashi, Kristela Jaupaj, Jerina Jaho, Llambi Subashi, Indrita Fejzaj, Ina Shuaipi
47 [GO] 2021―Jan―29 Worry Perception of the COVID-19 Pandemic in Children and Adolescents with Type 1 Diabetes Nouran Y. Salah, Amal Y. Abido, Hebatallah R. Rashed
48 [GO] 2021―Jan―29 A Telemedicine Approach For Assessment, Empowerment And Triage For COVID-19 Patients with Comorbidities Bijay Patni
49 [GO] 2021―Jan―07 Excess body weight is an independent risk factor for severe forms of COVID-19 Léa Pietri, Roch Giorgi, Audrey Bégu, Manon Lojou, Marie Koubi, Raphael Cauchois, et al. (+5)
50 [GO] 2020―Dec―07 Reply to Vitamin D deficiency in COVID-19: mixing up cause and consequence M. Chakhtoura, G. El Hajj Fuleihan
51 [GO] 2020―Nov―25 visceral fat is associated to the severity of COVID-19 Guillaume Favre, Kevin Legueult, Christian Pradier, Charles Raffaelli, Carole Ichai, Antonio Iannelli, et al. (+3)
52 [GO] 2020―Nov―20 Epicardial adipose tissue is associated with extent of pneumonia and adverse outcomes in patients with COVID-19 Kajetan Grodecki, Andrew Lin, Aryabod Razipour, Sebastien Cadet, Priscilla A. McElhinney, Cato Chan, et al. (+15)
53 [GO] 2020―Nov―19 Obesity, Diabetes, Non-alcoholic Fatty Liver Disease and Metabolic Dysfunction Associated Fatty Liver Disease are Proinflammatory Hypercoagulable States associated with Severe Disease and Thrombosis in Covid-19 Dong Ji, Mingjie Zhang, Enqiang Qin, Lunqing Zhang, Jing Xu, Yudong Wang, et al. (+3)
54 [GO] 2020―Nov―17 Letter to the editor: vitamin D deficiency in COVID-19: mixing up cause and consequence Joost Smolders, Jody van den Ouweland, Christopher Geven, Peter Pickkers, Mathijs Kox
55 [GO] 2020―Nov―04 Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: biomarker response to hypoglycemia Abu Saleh Md Moin, Ahmed Al-Qaissi, Thozhukat Sathyapalan, Stephen L. Atkin, Alexandra E. Butler
56 [GO] 2020―Oct―17 Mediterranean diet as a nutritional approach for COVID-19 Angeliki M. Angelidi, Alexander Kokkinos, Eleftheria Katechaki, Emilio Ros, Christos S. Mantzoros
57 [GO] 2020―Oct―17 Commentary: COVID-19 and Obesity Pandemics Converge into a Syndemic Requiring Urgent and Multidisciplinary Action Michael A. Hill, James R. Sowers, Christos S. Mantzoros
58 [GO] 2020―Oct―13 Metabolic impact of weight loss induced reduction of adipose ACE-2 - Potential implication in COVID-19 infections? Linna Li, Leonard Spranger, Dominik Soll, Finja Beer, Maria Brachs, Joachim Spranger, Knut Mai
59 [GO] 2020―Sep―28 Obesity in patients with COVID-19: a systematic review and meta-analysis Yi HUANG, L.U. Yao, Yan-Mei HUANG, Min WANG, Wei LING, Yi SUI, Hai-Lu ZHAO
60 [GO] 2020―Sep―23 Statins, COVID-19, and coronary artery disease: killing two birds with one stone Shiva Ganjali, Vanessa Bianconi, Peter E. Penson, Matteo Pirro, Maciej Banach, Gerald F. Watts, Amirhossein Sahebkar
61 [GO] 2020―Sep―16 Association of Body mass index (BMI) with Critical COVID-19 and in-hospital Mortality: a dose-response meta-analysis Yanbin Du, Yuan Lv, Wenting Zha, Nan Zhou, Xiuqin Hong
62 [GO] 2020―Aug―22 Obesity & genetic predisposition with COVID-19 Zhaozhong Zhu, Kohei Hasegawa, Baoshan Ma, Michimasa Fujiogi, Carlos A. Camargo, Liming Liang
63 [GO] 2020―Aug―22 Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: population-based, prospective cohort study Mark Hamer, Catharine R. Gale, G. David Batty
64 [GO] 2020―Jul―23 Visceral fat shows the strongest association with the need of intensive Care in Patients with COVID-19 Mikiko Watanabe, Damiano Caruso, Dario Tuccinardi, Renata Risi, Marta Zerunian, Michela Polici, et al. (+9)
65 [GO] 2020―Jul―23 Commentary. Eliminating Vitamin D Deficiency During the COVID-19 Pandemic: A Call to Action JoAnn E. Manson, Shari S. Bassuk
66 [GO] 2020―Jul―14 Commentary: COVID-19 and Obesity: Exploring Biologic Vulnerabilities, Structural Disparities, and Weight Stigma Matthew J. Townsend, Theodore K. Kyle, Fatima C. Stanford
67 [GO] 2020―Jul―14 The role of visceral adiposity in the severity of COVID-19: highlights from a unicenter cross-sectional pilot study in Germany Antonia Petersen, Keno Bressem, Jakob Albrecht, Hans-Martin Thieß, Janis Vahldiek, Bernd Hamm, et al. (+4)
68 [GO] 2020―Jun―24 Unexpected high mortality in COVID-19 and diabetic ketoacidosis Natalia Chamorro-Pareja, Sahana Parthasarathy, Jayabhargav Annam, Julie Hoffman, Christine Coyle, Preeti Kishore
69 [GO] 2020―Jun―21 Letter to the editor: Immunomodulation by phsphodiesterase-4 inhibitor in COVID-19 patients Alessandro Santaniello, Barbara Vigone, Lorenzo Beretta
70 [GO] 2020―Jun―01 Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19 Maria Dalamaga, Irene Karampela, Christos S. Mantzoros
71 [GO] 2020―May―26 Commentary: Myths and facts on vitamin D amidst the COVID-19 pandemic M. Chakhtoura, N. Napoli, G. El Hajj Fuleihan
72 [GO] 2020―May―16 Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York Leonidas Palaiodimos, Damianos G. Kokkinidis, Weijia Li, Dimitrios Karamanis, Jennifer Ognibene, Shitij Arora, et al. (+2)
73 [GO] 2020―May―08 Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens? Maria Dalamaga, Irene Karampela, Christos S. Mantzoros
74 [GO] 2020―Apr―30 The first Ramadan during COVID-19 pandemic: 1.8 billion Muslims should fast or not? Saeedeh Mosaferchi, Ehsan Sharif-Paghaleh, Alireza Mortezapour, Rashid Heidarimoghadam
75 [GO] 2020―Apr―29 Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease Abdulzahra Hussain, Peter Vasas, Shamsi EL-Hasani
76 [GO] 2020―Apr―28 Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy Casey Means
77 [GO] 2020―Apr―27 Testosterone, a key hormone in the context of COVID-19 pandemic Paolo Pozzilli, Andrea Lenzi
78 [GO] 2020―Apr―27 Obesity: The “Achilles heel” for COVID-19? Giovanna Muscogiuri, Gabriella Pugliese, Luigi Barrea, Silvia Savastano, Annamaria Colao
79 [GO] 2020―Apr―24 Mental Health and Psychological Distress in People with Diabetes during COVID-19 Sonia Mukhtazr, Sakina Mukhtar
80 [GO] 2020―Apr―23 Obesity hypoventilation syndrome and severe COVID-19 Jiao-Feng Huang, Xiao-Bo Wang, Kenneth I. Zheng, Wen-Yue Liu, Jun-Jie Chen, Jacob George, Ming-Hua Zheng
81 [GO] 2020―Apr―23 Importance of metabolic health in the era of COVID-19 Eleni Rebelos, Diego Moriconi, Agostino Virdis, Stefano Taddei, Diego Foschi, Monica Nannipieri
82 [GO] 2020―Apr―19 COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next Angeliki M. Angelidi, Matthew J. Belanger, Christos S. Mantzoros
83 [GO] 2020―Apr―19 Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease Kenneth I. Zheng, Feng Gao, Xiao-Bo Wang, Qing-Feng Sun, Ke-Hua Pan, Ting-Yao Wang, et al. (+4)
84 [GO] 2020―Apr―19 Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019 Junli Fan, Hui Wang, Guangming Ye, Xiaoling Cao, Xianqun Xu, Wenbin Tan, Yongxi Zhang
85 [GO] 2020―Apr―07 COVID-19 in patients with diabetes: risk factors that increase morbidity David C. Klonoff, Guillermo E. Umpierrez
86 [GO] 2020―Mar―24 Commentary: COVID-19 in Patients with Diabetes Michael A. Hill, Christos Mantzoros, James R. Sowers
87 [GO] 2020―Mar―24 Diabetes patients with COVID-19 need better care Jun Zhou, Jie Tan

87 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.013 sec